Skip to main content
Premium Trial:

Request an Annual Quote

David Spetzler

Caris Life Sciences has appointed David Spetzler its chief scientific officer. He was previously the company's senior vice president of R&D, and in his new role Spetzler will assume all responsibilities for Caris' research and product development efforts. A key new priority will be expanding the firm's focus on its Carisome TOP platform, a blood-based profiling technology being evaluated for applications in drug development and drug delivery, as well as for its diagnostic, prognostic, and theranostic use in cancer and other complex diseases, Caris said.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.